News
RLFTY
0.423
NaN%
--
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
Barchart · 03/18 21:35
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
Barchart · 12/14/2025 19:20
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
Barchart · 10/28/2025 21:20
Weekly Report: what happened at RLFTY last week (0908-0912)?
Weekly Report · 09/15/2025 11:14
Weekly Report: what happened at RLFTY last week (0901-0905)?
Weekly Report · 09/08/2025 11:17
Weekly Report: what happened at RLFTY last week (0825-0829)?
Weekly Report · 09/01/2025 11:12
Weekly Report: what happened at RLFTY last week (0818-0822)?
Weekly Report · 08/25/2025 11:23
Weekly Report: what happened at RLFTY last week (0811-0815)?
Weekly Report · 08/18/2025 11:15
More
Webull provides a variety of real-time RLFTY stock news. You can receive the latest news about MindMaze Therapeutics Holding SA through multiple platforms. This information may help you make smarter investment decisions.
About RLFTY
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.